Jump Financial’s Virax Biolabs VRAX Stock Holding History

Jump Financial’s Portfolio VRAX Stock Details VRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,629	Closed	-$8.96K	–	2509
2026 Q1	$8.96K	Buy	+1,629	New	+$9.99K	﹤0.01%	1809

Other funds holding VRAX

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jump Financial's VRAX Position: Q2 2026 in Review

Jump Financial sold out of Virax Biolabs (VRAX) in Q2 2026, closing a stake of 1,629 shares — an estimated $8.96K sold.

Jump Financial first reported a position in VRAX in Q1 2026 and held it in 1 quarter. The position peaked at $8.96K in Q1 2026. 2 funds tracked by Wall St. Rank hold VRAX as of Q2 2026.

Jump Financial reported no remaining Virax Biolabs position as of Q2 2026 after selling out during the quarter.
Jump Financial sold 1,629 Virax Biolabs shares in Q2 2026, an estimated $8.96K.
Jump Financial first reported a position in Virax Biolabs in Q1 2026 and held it in 1 quarter.
Jump Financial's Virax Biolabs position peaked at $8.96K in Q1 2026.
2 funds tracked by Wall St. Rank held Virax Biolabs as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.